Related Experiment Video
Updated: Aug 19, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
Interaction of Tau with Fe65 links tau to APP
Christian Barbato1, Nadia Canu, Nicola Zambrano
1Dipartimento di Neuroscienze, Università di Roma Tor Vergata, Via Montpellier 1, 00133 Roma, Italy.
Abstract:
The beta-amyloid precursor protein APP and the microtubule-associated protein Tau play a crucial role in the pathogenesis of Alzheimer's disease (AD). However, the possible molecular events linking these two proteins are still unknown. Here, we show that Fe65, one of the ligands of the APP cytodomain, is associated with Tau in vivo and in vitro, as demonstrated by co-immunoprecipitation, co-localization, and FRET experiments. Deletion studies indicated that the N-terminal domain of Tau and the PTB1 domain of Fe65 are required for this association. This interaction is regulated by the phosphorylation of Tau at selected sites, by glycogen synthase kinase-3beta (GSK3beta) and cyclin-dependent kinase 5 (Cdk5), and requires an intact microtubule network. Furthermore, laser scanner microscopy and co-immunoprecipitation experiments provide preliminary evidence of possible complex(es) involving Tau, Fe65, APP. These findings open new perspectives for the study of the possible crosstalk between these proteins in the pathogenesis of AD.
Insights
Fe65 protein links Alzheimer's disease (AD) proteins APP and Tau. This interaction, crucial for AD pathogenesis, is regulated by Tau phosphorylation and requires an intact microtubule network.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Alzheimer's disease (AD) pathogenesis involves beta-amyloid precursor protein (APP) and Tau.
- Molecular links between APP and Tau in AD remain unclear.
Purpose of the Study:
- Investigate the molecular mechanisms linking APP and Tau.
- Determine if Fe65, an APP-binding protein, interacts with Tau.
Main Methods:
- Co-immunoprecipitation and co-localization assays to detect protein interactions.
- Förster Resonance Energy Transfer (FRET) to confirm in vivo association.
- Deletion studies to identify interaction domains.
- Analysis of Tau phosphorylation by GSK3beta and Cdk5.
- Laser scanner microscopy to visualize protein complexes.
Main Results:
- Fe65 associates with Tau both in vivo and in vitro.
- The N-terminal domain of Tau and the PTB1 domain of Fe65 are essential for this interaction.
- Tau phosphorylation by GSK3beta and Cdk5 regulates Fe65-Tau binding.
- An intact microtubule network is required for the interaction.
- Preliminary evidence suggests complexes involving Tau, Fe65, and APP.
Conclusions:
- Fe65 acts as a molecular bridge between APP and Tau.
- This Fe65-mediated interaction is a potential therapeutic target for Alzheimer's disease.
- Findings reveal novel crosstalk between key AD-related proteins.
Related Concept Videos
Microtubule Associated Proteins (MAPs)
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...

